Literature DB >> 24866765

Invasive cutaneous squamous cell carcinoma incidence in US health care workers.

Khang D Nguyen1, Jiali Han, Tricia Li, Abrar A Qureshi.   

Abstract

Little data on cutaneous squamous cell carcinoma (SCC) epidemiology within the United States are currently available. Prior studies have focused on populations outside of the United States or been limited to regions within the US. In this study, prospective data were collected via biennial questionnaires from a total of 261,609 participants, which included women in the Nurses' Health Study (NHS, 1976-2008) and Nurses' Health Study II (NHS II, 1989-2009), and men in the Health Professionals Follow-Up Study (HPFS, 1986-2008). History of physician-diagnosed invasive SCC was confirmed by pathology record review. Over the entire follow-up period for each cohort, there were 1,265 invasive SCC cases per 100,000 persons in the NHS cohort, 389 cases per 100,000 persons in NHS II, and 2,154 cases per 100,000 persons in HPFS. An 18-year follow-up of participants in these cohorts revealed increasing invasive SCC incidence rates over time, with rates for men being consistently higher than those for women. In women, a larger proportion of invasive SCC lesions occurred on the lower extremities as compared to men (21 % in NHS vs. 6 % in HPFS, p < 0.0001; 14 % in NHS II vs. 6 % in HPFS, p < 0.0001), while in men, a larger proportion occurred on the head/neck (43 % in NHS vs. 60 % in HPFS, p < 0.0001; 48 % in NHS II vs. 60 % in HPFS, p < 0.0001). In summary, invasive SCC incidence rates among US men have been greater than those for women with distinct sites of common occurrence between men and women.

Entities:  

Mesh:

Year:  2014        PMID: 24866765      PMCID: PMC4186740          DOI: 10.1007/s00403-014-1469-3

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  12 in total

1.  Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group.

Authors:  M R Karagas; E R Greenberg; S K Spencer; T A Stukel; L A Mott
Journal:  Int J Cancer       Date:  1999-05-17       Impact factor: 7.396

2.  Melanoma incidence and mortality among US whites, 1969-1999.

Authors:  Alan C Geller; Donald R Miller; George David Annas; Marie-France Demierre; Barbara A Gilchrest; Howard K Koh
Journal:  JAMA       Date:  2002-10-09       Impact factor: 56.272

3.  Incidence estimate of nonmelanoma skin cancer in the United States, 2006.

Authors:  Howard W Rogers; Martin A Weinstock; Ashlynne R Harris; Michael R Hinckley; Steven R Feldman; Alan B Fleischer; Brett M Coldiron
Journal:  Arch Dermatol       Date:  2010-03

4.  Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996.

Authors:  R B Harris; K Griffith; T E Moon
Journal:  J Am Acad Dermatol       Date:  2001-10       Impact factor: 11.527

Review 5.  The epidemiology of skin cancer.

Authors:  Thomas L Diepgen; V Mahler
Journal:  Br J Dermatol       Date:  2002-04       Impact factor: 9.302

6.  Melanoma awareness and self-examination practices: results of a United States survey.

Authors:  D R Miller; A C Geller; S W Wyatt; A Halpern; J B Howell; C Cockerell; B A Reilley; B A Bewerse; D Rigel; L Rosenthal; R Amonette; T Sun; T Grossbart; R A Lew; H K Koh
Journal:  J Am Acad Dermatol       Date:  1996-06       Impact factor: 11.527

7.  Nonmelanoma skin cancer in the United States: incidence.

Authors:  D L Miller; M A Weinstock
Journal:  J Am Acad Dermatol       Date:  1994-05       Impact factor: 11.527

8.  Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012.

Authors:  Pritesh S Karia; Jiali Han; Chrysalyne D Schmults
Journal:  J Am Acad Dermatol       Date:  2013-02-01       Impact factor: 11.527

9.  Changes in nonmelanoma skin cancer incidence between 1977-1978 and 1998-1999 in Northcentral New Mexico.

Authors:  William F Athas; William C Hunt; Charles R Key
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-10       Impact factor: 4.254

10.  Skin cancer is among the most costly of all cancers to treat for the Medicare population.

Authors:  Tamara Salam Housman; Steven R Feldman; Phillip M Williford; Alan B Fleischer; Neal D Goldman; Jose M Acostamadiedo; G John Chen
Journal:  J Am Acad Dermatol       Date:  2003-03       Impact factor: 11.527

View more
  3 in total

1.  Gender Disparity and Mutation Burden in Metastatic Melanoma.

Authors:  Sameer Gupta; Mykyta Artomov; William Goggins; Mark Daly; Hensin Tsao
Journal:  J Natl Cancer Inst       Date:  2015-08-20       Impact factor: 13.506

2.  Are FDA-Approved Sunscreen Components Effective in Preventing Solar UV-Induced Skin Cancer?

Authors:  Ann M Bode; Eunmiri Roh
Journal:  Cells       Date:  2020-07-11       Impact factor: 6.600

3.  Identifying Susceptibility Loci for Cutaneous Squamous Cell Carcinoma Using a Fast Sequence Kernel Association Test.

Authors:  Manyan Huang; Chen Lyu; Xin Li; Abrar A Qureshi; Jiali Han; Ming Li
Journal:  Front Genet       Date:  2021-05-10       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.